Form 4: Angiodynamics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Chad Thomas Campbell, SVP/GM, Vascular Access of Angiodynamics Inc, reported multiple transactions in common stock on July 22, 2026.
Summary
- Option exercise/conversion: acquired 6,466 Common Stock on July 22, 2026; holds 111,006 after (Direct).
- Tax/exercise-price withholding: disposed of 2,330 Common Stock at $13.82 ($32,201) on July 22, 2026; holds 108,676 after (Direct).
- Option exercise/conversion: disposed of 22,768 Performance Right on July 22, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Chad Thomas Campbell — Officer (SVP/GM, Vascular Access)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-22 | Option exercise/conversion | Common Stock | 6,466 | — | — | 111,006 |
| 2026-07-22 | Tax/exercise-price withholding | Common Stock | 2,330 | $14 | $32.2K | 108,676 |
| 2026-07-22 | Option exercise/conversion | Performance Right | 22,768 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-22 | Option exercise/conversion (6,466 shares) |
| 2026-07-22 | Tax/exercise-price withholding (2,330 shares) |
| 2026-07-22 | Option exercise/conversion (22,768 shares) |
Keywords
insider transaction, Form 4, ANGO, ANGIODYNAMICS INC, neutral, Chad Thomas Campbell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.